Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP301874.RApMLiG4a8e4kXeSY9ECP4sfuhGvUWrjTf2n5Dxzw6FT4130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP301874.RApMLiG4a8e4kXeSY9ECP4sfuhGvUWrjTf2n5Dxzw6FT4130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP301874.RApMLiG4a8e4kXeSY9ECP4sfuhGvUWrjTf2n5Dxzw6FT4130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP301874.RApMLiG4a8e4kXeSY9ECP4sfuhGvUWrjTf2n5Dxzw6FT4130_provenance.
- NP301874.RApMLiG4a8e4kXeSY9ECP4sfuhGvUWrjTf2n5Dxzw6FT4130_assertion description "[In this study, we investigated the influence of the genetic polymorphisms GSTM1, GSTT1, and GSTP1 on treatment response in 94 Korean patients with de novo diffuse large B-cell lymphoma, who had received rituximab plus cyclophosphamide/doxorubicin/vincristine/prednisone (R-CHOP) as a front-line regimen.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP301874.RApMLiG4a8e4kXeSY9ECP4sfuhGvUWrjTf2n5Dxzw6FT4130_provenance.
- NP301874.RApMLiG4a8e4kXeSY9ECP4sfuhGvUWrjTf2n5Dxzw6FT4130_assertion evidence source_evidence_literature NP301874.RApMLiG4a8e4kXeSY9ECP4sfuhGvUWrjTf2n5Dxzw6FT4130_provenance.
- NP301874.RApMLiG4a8e4kXeSY9ECP4sfuhGvUWrjTf2n5Dxzw6FT4130_assertion SIO_000772 20303013 NP301874.RApMLiG4a8e4kXeSY9ECP4sfuhGvUWrjTf2n5Dxzw6FT4130_provenance.
- NP301874.RApMLiG4a8e4kXeSY9ECP4sfuhGvUWrjTf2n5Dxzw6FT4130_assertion wasDerivedFrom befree-20140225 NP301874.RApMLiG4a8e4kXeSY9ECP4sfuhGvUWrjTf2n5Dxzw6FT4130_provenance.
- NP301874.RApMLiG4a8e4kXeSY9ECP4sfuhGvUWrjTf2n5Dxzw6FT4130_assertion wasGeneratedBy ECO_0000203 NP301874.RApMLiG4a8e4kXeSY9ECP4sfuhGvUWrjTf2n5Dxzw6FT4130_provenance.
- befree-20140225 importedOn "2014-02-25" NP301874.RApMLiG4a8e4kXeSY9ECP4sfuhGvUWrjTf2n5Dxzw6FT4130_provenance.